Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association
Recommended Citation
Fox CS, Hall JL, Arnett DK, Ashley EA, Delles C, Engler MB, Freeman MW, Johnson JA, Lanfear DE, Liggett SB, Lusis AJ, Loscalzo J, MacRae CA, Musunuru K, Newby LK, O'Donnell CJ, Rich SS, Terzic A. Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. Circulation 2015; 131(19):1715-1736.
Document Type
Article
Publication Date
5-12-2015
Publication Title
Circulation
Abstract
The field of genetics and genomics has advanced considerably with the achievement of recent milestones encompassing the identification of many loci for cardiovascular disease and variable drug responses. Despite this achievement, a gap exists in the understanding and advancement to meaningful translation that directly affects disease prevention and clinical care. The purpose of this scientific statement is to address the gap between genetic discoveries and their practical application to cardiovascular clinical care. In brief, this scientific statement assesses the current timeline for effective translation of basic discoveries to clinical advances, highlighting past successes. Current discoveries in the area of genetics and genomics are covered next, followed by future expectations, tools, and competencies for achieving the goal of improving clinical care.
Medical Subject Headings
American Heart Association; Animals; Biotransformation; Cardiovascular Agents; Cardiovascular Diseases; Drug Evaluation, Preclinical; Forecasting; Genetic Variation; Genomics; Human Genome Project; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Induced Pluripotent Stem Cells; Mice; Molecular Targeted Therapy; Translational Medical Research; United States
PubMed ID
25882488
Volume
131
Issue
19
First Page
1715
Last Page
1736
